NYSE$ZTS

Zoetis · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Reported revenue of $2.0 billion, growing 6%, and net income of $595 million, or $1.26 per diluted share, increasing 6% and 8%, respectively, on a reported basis.

Zoetis reported a strong first quarter in 2022, with revenue reaching $2.0 billion, a 6% increase compared to the previous year. Net income increased by 6% to $595 million, with diluted earnings per share rising by 8% to $1.26. Adjusted net income was $625 million, or $1.32 per diluted share, representing a 4% increase. The company has updated its full-year guidance to reflect the negative impact of foreign exchange rates.

  • Revenue reached $2.0 billion, a 6% increase, with net income at $595 million, up 6%.
  • Operational revenue growth was strong at 9%, and adjusted net income grew by 8% operationally.
  • The U.S. segment saw a 9% increase in revenue, driven by companion animal products.
  • The international segment grew by 3% on a reported basis and 8% operationally, with companion animal products as a key driver.

Headline financials

Total Revenue

$1.99B

Previous: $1.87B+6.1%
EPS (adj)

$1.32

Previous: $1.26+4.8%
Companion Animal Growth

17.0%

Previous: 34.0%-50.0%
Livestock Growth

-9.0%

Previous: 8.0%-212.5%
U.S. Revenue Growth

9.0%

Previous: 19.0%-52.6%
International Revenue Growth

3.0%

Previous: 25.0%-88.0%
Capital Expenditures

-$115M

Previous: -$77M-49.4%
Free Cash Flow

$480M

Previous: $482M-0.4%
Net Income

$595M

Previous: $559M+6.4%
Operating Income

$777M

Previous: $737M+5.4%
Gross Profit

$1.42B

Previous: $1.32B+7.2%
Cash & Equivalents

$3.14B

Previous: $3.6B-13.0%
Total Assets

$13.9B

Previous: $13.8B+0.5%
Stock-Based Comp

$16M

Previous: $13M+23.1%

Revenue & EPS history

Zoetis · Revenue · Quarterly

$1.99B

Q1 2022+6.1%vs Q1 2021
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Zoetis · $1.99B total across 3 segments · Q1 2022

  • Companion Animal
    $1.26B+17.4%
  • Livestock
    $705M-9.5%
  • Contract Mfg & Human Health
    $18M+12.5%

Forward guidance

Zoetis is updating its full year 2022 guidance due to the negative impact of recent changes to foreign exchange rates, and this includes: Revenue between $8.225 billion to $8.375 billion, Reported diluted EPS between $4.65 to $4.77, Adjusted diluted EPS between $4.99 to $5.09.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.4%

Avg return

Earnings day

-0.6%

Avg return

5 days after

+0.5%

Avg return

30 days after

55%

32 / 58 earnings

Positive

+8.1%

Q4 2018

Best reaction

-13.7%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%-30.9%-28.5%
Q4 2025-2.4%-2.4%-10.1%
Q3 2025-13.7%-16.7%-16.6%
Q2 2025-3.7%-2.9%+0.9%
Q1 2025-5.3%+0.8%+6.7%
Q4 2024-5.1%-10.0%-7.3%
Q3 2024-3.7%-2.8%-3.6%
Q2 2024+5.7%+6.0%+6.7%
Q1 2024+5.4%+6.3%+7.0%
Q4 2023-6.4%-4.2%-11.6%
Q3 2023+7.1%+10.4%+18.3%
Q2 2023+4.8%+5.6%+3.9%
Q1 2023+4.8%+3.7%-3.3%
Q4 2022+7.3%+5.4%+1.9%
Q3 2022-9.3%-7.6%+6.8%
Q2 2022-3.1%-5.9%-12.9%
Q1 2022-4.3%-8.0%-4.4%
Q4 2021-0.7%-2.6%-1.4%
Q3 2021+2.7%+4.3%+5.8%
Q2 2021-1.4%-2.9%+2.4%
Q1 2021-1.3%-2.1%+0.8%
Q4 2020+1.3%-4.0%-8.6%
Q3 2020-2.9%-6.8%-9.4%
Q2 2020+0.7%-0.5%-0.3%
Q1 2020-5.4%-3.7%+7.4%
Q4 2019+0.8%+0.5%-12.2%
Q3 2019-3.0%-3.5%+0.2%
Q2 2019+7.4%+11.1%+13.8%
Q1 2019+1.9%-0.4%-0.7%
Q4 2018+8.1%+7.5%+9.8%
Q3 2018+2.9%+2.9%+4.1%
Q2 2018+6.5%+7.5%+5.3%
Q1 2018-3.6%-1.5%+2.4%
Q4 2017+7.1%+7.9%+13.6%
Q3 2017+6.5%+6.1%+12.1%
Q2 2017-1.6%-3.4%+4.9%
Q1 2017+7.0%+6.9%+12.4%
Q4 2016-4.8%-3.0%-2.1%
Q3 2016+3.6%+5.8%+3.9%
Q2 2016+3.4%+2.2%+3.1%
Q1 2016+0.2%
Q4 2015+3.4%
Q3 2015+5.2%
Q2 2015+0.3%
Q1 2015-0.2%
Q4 2014+4.3%
Q3 2014+4.1%
Q2 2014-2.8%
Q1 2014+0.4%
Q4 2011+0.1%
Q4 2013-3.7%
Q3 2012-0.5%
Q3 2013-2.1%
Q2 2012-1.4%
Q2 2013-0.0%
Q1 2012+0.9%
Q4 2012+0.9%
Q1 2013+2.2%
Q3 2011
Q2 2011
Q1 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro